Optimizing Immunotherapy Combined With Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Clinical trial NCT07040098 · RECRUITING

Trial details

NCT number: NCT07040098
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Rectal Cancer (LARC)

Start date: 2025-06-01
Primary completion: 2027-06-30
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.